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Abstract
The present review focuses on the current knowledge of
the neurochemical processes and neuronal structures
involved in the generation of P300. The increasing
knowledge in this area facilitates the physiological inter-
pretation of P300 findings as well as the link between
P300 research and other research findings in biological
psychiatry. Concerning the question of neurochemical
substrates, the glutamatergic, GABAergic, cholinergic,
noradrenergic, dopaminergic and serotonergic in-
fluences on P300 are reviewed. The knowledge of the
generating structures of P300 is summarized from intra-
cranial studies, magnetoencephalographic investiga-
tions, lesion and animal studies.
Introduction
Thirty-three years have passed since Sutton et al. [1]
first described long-latency positive event-related poten-
tials (ERPs). Now commonly referred to as the P300 (also
called P3, P3b or LPC), this positive ERP occurs with a
latency of about 300 ms after meaningful task-relevant
target stimuli (fig. 1). It is often elicited with a simple dis-
crimination task, the ‘oddball paradigm’. In this para-
digm, two different stimuli are presented, with task-rele-
vant target stimuli occurring less frequently than the non-
target or standard stimuli (e.g. with probabilities 0.20 and
0.80, respectively). The subject’s task can be, for example,
to press a button or to silently count the task-relevant
stimuli which are presented in auditory, visual, somato-
sensory or olfactory modalities.
In the following years, P300 was studied extensively
with different methods and paradigms. Most of these
studies focused on the relationship between P300 and
psychological principally cognitive aspects. Major theo-
retical interpretations of P300 amplitude are that it
indexes the updating of the working memory [2], or that it
reflects context closure [3]. Considering experimental
conditions, P300 amplitude is related to stimulus proba-
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Fig. 1.  The P300 can be typically elicited
with a discrimination paradigm. A task-rele-
vant target stimulus occurs less frequently
than a nontarget stimulus (e.g. with probabil-
ities 0.20 and 0.80, respectively). P300 is a
positive ERP with a maximum at the parie-
tocentral electrodes which occurs at about
300 ms after a task-relevant target stimulus
when the subject has to perform a task, for
example to press a button or to count the tar-
get stimuli (waveform at the bottom). After
the occurrence of the nontarget stimulus no
P300 is elicited (waveform at the top).
bility, stimulus significance, task difficulty, motivation
and vigilance [4]. P300 latency is mainly influenced by
the task complexity and is a reflection of stimulus evalua-
tion and of response processing when response times are
short under fast experimental conditions [reviewed in 5].
Alterations of P300 have been found in various psy-
chiatric disorders. In schizophrenia, P300 amplitude re-
duction is one of the most robust biological findings [6, 7].
Reduced P300 amplitudes were found to predict a bad
clinical outcome with antipsychotic treatment [8], incom-
plete remission [9] and a higher risk for tardive dyskinesia
[10]. Furthermore, P300 latency was prolonged in some
studies of schizophrenia [11]. In dementia, P300 ampli-
tude reductions and latency prolongations have consis-
tently been reported [12, 13]. These findings raised the
question whether or not P300 could aid in the diagnosis of
dementia [12, 14]. Moreover, P300 amplitudes were re-
duced in alcoholics and family members of alcoholics
[15]. Furthermore, prolongations of P300 latency were
reported in patients with HIV [16] and idiopathic parkin-
sonism [17]. In patients with depression, less consistent
findings were made about P300 amplitude or latency.
The physiological interpretation of P300 data, how-
ever, has remained difficult, because among other prob-
lems, the question of its neural origin has not been solved.
Knowledge of the neurochemical and neuroanatomical
substrates of P300 would be important for the physiologi-
cal interpretation of P300 findings and for relating P300
research to other research areas, such as neurochemical
and neuroanatomical studies in psychiatry. The aim of
this review is to summarize the present knowledge of the
neurochemical processes and the neural structures in-
volved in the generation of the auditory P300.
Neurochemical Substrates of the P300
The increasing knowledge of the anatomical structures
and cellular processes underlying ERPs, and the method-
ological advances in analysis of ERPs offer a possibility to
bridge the gap between ERPs and their basic neurophysi-
ology. It is now widely accepted that ERPs result from
intracortical currents induced by excitatory and inhibito-
ry postsynaptic potentials (EPSPs, IPSPs), which are trig-
gered by the release of neurotransmitters. Therefore,
ERPs reflect postsynaptic effects of neurotransmitters like
glutamate and GABA and indirect modulating effects
from neuromodulators like acetylcholine, noradrenaline,
dopamine or serotonine. They could become of clinical
value as indicators for disturbances in these neurochemi-
cal systems. However, P300 can only be used as such an
indicator when at least a certain specificity exists in the
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relationship between P300 and the different neurochemi-
cal systems. Therefore, it is necessary to characterize the
role of neurotransmitters in the generation of P300.
Glutamatergic Influences
Physiological analysis and the application of the cur-
rent source density method to intracortical recordings
suggest that the EPSPs from the apical dendrites with
sources in deeper layers near or at the soma are most like-
ly to be responsible for slow cortical potentials [18] such
as P300. The N-methyl-D-aspartate (NMDA) receptors,
which are activated by glutamate could be of special
importance. The glutamatergic system is the most impor-
tant excitatory neurotransmitter system and plays an im-
portant role in the electrogenesis of P300 potentials [19].
As discussed, for example, by Javitt et al. [20], these
receptors have long EPSPs of 10–100 ms, which seem to
correspond to late components such as P300. Further-
more, the effect of NMDA receptor activity on ERPs has
been shown in animal experiments with intracranial re-
cordings [20]. MK-801, a high-affinity high-specificity
NMDA channel blocker, was administered intracortically
in a monkey. The mismatch negativity (MMN), a late cog-
nitive ERP, was reduced after the administration of MK-
801. MMN precedes P300 and shares similarities with
P300 because both P300 and MMN are events in the pro-
cessing of stimulus deviance.
In addition, P300 and the NMDA receptor function
have a remarkable similarity. Both P300 and NMDA
receptor function depend on preconditions. The P300
component is elicited only after task-relevant stimuli. It is
dependent on the precondition that a series of irrelevant
standard stimuli has been presented when the deviating
task-relevant stimuli occurs. On the other hand, poten-
tials of NMDA receptors are blocked in a voltage-depen-
dent fashion by Mg2+. The NMDA receptor function is
dependent on the degree of membrane depolarization
and, therefore, like P300, has a conditional aspect.
In summary, P300 is most likely caused by a direct
excitatory postsynaptic effect of glutamatergic neuro-
transmission.
GABAergic Influences
GABA is the most important inhibitory neurotrans-
mitter, and IPSPs triggered by GABAergic effects could
also be responsible for late ERPs such as P300. The
GABAergic transmission in the reticular nucleus of the
thalamus has been suggested to contribute to positive cor-
tical potentials via inhibitory hyperpolarization [21].
Then, indirect inhibitory influences on GABAergic IPSPs
could reduce the negativity of some cortical brain regions
and, therefore, could be measured as positive potentials.
However, the findings from current source density meth-
ods point in another direction. It is more likely that slow
cortical potentials are directly caused by EPSPs and not
by IPSPs.
Another explanation of the GABAergic effects on P300
is that GABAergic influences decrease EPSPs [22] and,
therefore, reduce P300. This is supported by findings
which showed that sedating GABAergic drugs alter P300
parameters. P300 amplitudes were reduced [23, 24] and
P300 latencies were delayed after the application of GA-
BAergic drugs [25, 26].
Taken together, the present results indicate that GA-
BAergic influences on P300 generation are most likely to
be indirect. These effects on P300 could result from inhib-
itory influences on glutamatergic EPSPs.
Cholinergic Influences
The cholinergic neurotransmitter system has indirectly
modulating effects in widely distributed neuronal net-
works. Acetylcholine has been found to be involved in the
generation of P300 [27]. Memory performance and P300
amplitude is increased after the administration of cholin-
ergic substances and is reduced after the administration of
anticholinergic substances [28–30]. Scopolamine, an anti-
cholinergic substance, significantly reduces the P300 am-
plitude and increases its latency [31, 32]. The muscarinic
agonist RS 86 increases P300 amplitudes in patients with
Alzheimer’s disease [33].
Furthermore, animal studies investigating the in-
fluence of the septal cholinergic system on P300 [34, 35]
found that septal cholinergic system lesions affect P300 in
cats. The septal nuclei provide the major cholinergic
input to the hippocampus (from the diagonal band of Bro-
ca and the medial septal nuclei) and to the neocortex
(from the nucleus basalis of Meynert). However, it is not
clear to what extend findings from animal studies can
be generalized to explain neurochemical processes in hu-
mans.
In summary, the cholinergic system is an important
neuromodulator of the P300-evoked potentials.
Noradrenergic Influences
Another important neuromodulator is noradrenaline.
The results on the influences of noradrenergic substances
on P300 are inconsistent. Findings on the influence of the
substances clonidine, methylphenidate and D-amphet-
amine are difficult to interpret because these substances
have not only adrenergic, but also dopaminergic, seroton-
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ergic or cholinergic activity. Clonidine, an alpha-2 adren-
ergic agonist, which reduces the firing rate of the locus
ceruleus, slowed P300 latency and decreased P300 ampli-
tude [36–38]. However, clonidine may produce anticho-
linergic effects which influence P300 per se [39]. Methyl-
phenidate enhanced P300 amplitude in attention-deficit
hyperactivity disorder children [40]. On the other hand,
methylphenidate and D-amphetamine have also been
found to not affect P300 [41, 42]. Therefore, further
investigations are necessary to define the influences of
adrenergic substances on P300 in humans.
In contrast to the inconsistencies concerning findings
in humans, results from animal studies suggest that the
noradrenergic system has a role in P300 generation. The
noradrenergic locus ceruleus system has been implicated
in information processing similar to that presumed to be
indexed by P300-like potentials [43]. Lesions of the nor-
adrenergic locus ceruleus caused reductions of P300 am-
plitude [44]. When clonidine was administered to 6 adult
monkeys during an auditory ‘oddball paradigm’, a signifi-
cant decrease in P300-like activity was observed [45].
Moreover, microinjections of alpha-2 antagonists and ag-
onists in the temporoparietal junction resulted in signifi-
cant reductions of P300 amplitudes in monkeys [46]. A
model that could explain the inconsistent findings in
humans and the adrenergic effects in animals proposes
that noradrenaline has, at least to some extent, an inhibi-
tory control on GABAergic activity. This indirect effect
could contribute via inhibitory hyperpolarization to posi-
tive slow cortical potentials like P300 [21, 22].
In summary, the adrenergic neuromodulator system
seems to have minor influences on P300 elicited during
P300 recordings in humans. Stronger noradrenergic ef-
fects on P300 have been demonstrated under experimen-
tal conditions in animal studies.
Dopaminergic Influences
Stanzione et al. [17] suggested that dopaminergic neu-
rotransmission has a physiological role in the generation
of P300. They studied P300 in idiopathic parkinsonian
patients, in whom destruction of dopaminergic fibers was
described, and found that P300 latency was increased
before therapy. Therapy with L-DOPA plus benserazide
reduced the prolonged latency. Taken together, the stud-
ies on patients with Parkinson’s disease show prolonged
P300 latencies for demented patients, whereas the results
in nondemented patients concerning P300 latency and
amplitude were inconsistent. Because of the influence of
dementia in these studies, the disturbances in the dopa-
minergic system do not seem to be specific for these P300
findings. Another finding which speaks against an impor-
tant role of the dopaminergic system in P300 generation is
that dopaminergic fibers do not seem to be necessary for
P300 because toxic lesions of these fibers do not affect the
monkey P300 [47].
In summary, the dopaminergic system seems to play a
minor role in the generation of P300 processes.
Serotonergic Influences
Effects of the serotonergic agent fenfluramine and the
antiserotonergic agent methysergide on P300 have not
been reported until now. A prolongation of P300 latency
only appears with combinations of antiserotonergic with
anticholinergic substances [48]. These findings seem to
focus on the interactive role between serotonergic and
cholinergic substances in EEG modulation [49].
Further investigations will be needed to evaluate the
neurobiological effect of serotonergic activity on P300. To
date, the serotonergic system does not seem to have a
modulatory role in P300 generation.
Summary of Findings on the Neurochemical
Substrates of P300
Various neurochemical influences were found on P300
generation. A model of neurochemical influences on P300
is presented in figure 2. P300 generation is triggered by
the neurotransmitter glutamate, which is the most impor-
tant excitatory neurotransmitter. An important modula-
tor of these EPSPs caused by glutamate and, therefore, of
this P300 activity is the cholinergic neurotransmission,
which increases P300 amplitude and decreases P300
latency. On the other hand, GABAergic influences on
EPSPs reduce P300 amplitude and prolong P300 latency.
Other neuromodulator systems seem to be less impor-
tant for P300 generation. They seem to have, at least to
some extent, indirect influence on other neurochemical
systems like the GABAergic and cholinergic system,
which are important for P300 generation. Modulation of
any one neurochemical system will necessarily modulate
many other neurochemical systems.
This complex pattern of neurotransmitter influences
can explain why P300 is altered in several psychiatric dis-
orders. Considering the glutamate hypothesis in schizo-
phrenia, the reduced amplitude of P300 in schizophrenics
could stem from disturbances in the glutamatergic sys-
tem. Reduced amplitudes and prolonged latencies of
P300 in dementia could be due to alterations in the cho-
linergic system.
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Fig. 2.  Findings about neurochemical sub-
strates of the P300 suggest this hypothetical
model of P300 generation. The glutamater-
gic neurotransmission directly causes the
EPSPs, which are responsible for the P300
activity. These EPSPs and as a consequence
the P300 are modulated both indirectly by
influences of acetylcholine, enhancing P300
amplitude and decreasing P300 latency, and
by influences of GABA, reducing P300 am-
plitude and prolonging P300 latency. The
adrenergic system and with minor impor-
tance, the dopaminergic and serotonergic
systems seem to have indirect influence on
the indirect effects of the acetylcholinergic
and GABAergic systems and, thus, have
shown inconsistent findings concerning
P300 in humans.
Generators of P300
In this section we will review the macroanatomical
P300 generators. The distribution of the electric fields
throughout the brain and at the surface of the scalp is
determined by the spatial distribution of the neurons as
well as by the geometry and impedance of the brain and
its coverings [50]. The presupposition for summing up
microfield activities and for producing a so-called ‘far or
open field’, which is volume conducted to the surface, is
that the neurons have a laminar and columnal organiza-
tion. This is the case for cortical neurons. Otherwise,
when microfields cancel each other, they are named
‘closed fields’. Neuronal activity within closed fields will
not be recorded in the scalp data.
P300 seems to be more complex than previously
thought. Indeed, P300 is a composite of the activity aris-
ing from different brain generators [51]. Invasive meth-
ods, like intracranial recordings, lesion studies, lobectomy
investigations and animal studies can provide evidence
for the localization of P300 generators.
A number of studies analyzing P300 with intracranial
electrodes have suggested the importance of the medial
temporal lobe structures for P300 generation. Halgren et
al. [52] recorded large P300 potentials from electrodes
implanted in the hippocampus, parahippocampal gyrus
and amygdala of epileptic patients. Okada et al. [53] and
Wood et al. [54] found comparable results from studies
using simultaneous scalp recordings. These results indi-
cated a local origin of the P300 in the limbic system. Stud-
ies demonstrating the broad P300 scalp distribution were
consistent with a deep generator [55, 56].
However, the newest evidence shows that the limbic
system probably has only a small influence on the genera-
tion of the scalp-recorded P300 because of several rea-
sons:
(1) The hippocampus does not seem to produce a far
field large enough to be measured at the scalp electrodes
because of its special anatomy and its location deep in the
temporal lobe. Deep structures, such as the hippocampus,
are unlikey to be direct generators of the large 10–20 ÌV
P300-potentials recorded on the scalp [57].
(2) The studies of Paller et al. [58] presented evidence
against the hippocampal generation of P300. The P300
wave was still present in monkeys with bilateral excisions
to the medial temporal lobe. Arguments against these
studies were that the excisions may not have affected all
P300-generating structures in the temporal lobe or that
other structures compensated for the disturbances.
(3) Investigations in epileptic patients after temporal
lobectomies did not show any significant difference from
normal subjects as to P300 [59–62]. However, the posteri-
or hippocampus, which can produce large P300-like am-
plitudes [63], typically is spared in lobectomies. Thus, this
argument does not exclude a far-field P300 generator in
the posterior hippocampus.
(4) A patient with extensive damage to the left medial
temporal lobe caused by an infiltrating glioma did not
have changed P300 parameters [64].
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(5) Recent investigations with intracranial electrode
recordings have provided the best knowledge of P300 gen-
erators [65, 66]. It was concluded that the strong voltage
gradients of hippocampal activity make a direct participa-
tion of this structure in the production of P300 scalp
potentials unlikely.
P300 activity was observed with intracranial elec-
trodes in multiple sites of the temporal and parietal cor-
tices. These structures were the posterior and superior
parietal cortices [65, 66], the parietooccipital cortex [67],
the inferior parietal lobule [68], the marginal gyrus [69],
the sulcus temporalis superior [65, 66] and the posterior
cingulate gyrus [66]. These findings are supported by
lesion studies. Yamaguchi and Knight [70] found reduced
P300 in patients with temporoparietal lesions, and Ver-
leger [71] replicated this finding. Yamaguchi and Knight
[70] also reported that unilateral damage to the temporo-
parietal cortex decreases P300 over both hemispheres.
Therefore, the integrity of the temporoparietal junction
seems to be necessary for P300 generation.
Furthermore, correlations of magnetic resonance
imaging with P300 amplitudes [72] raise the possibility
that the temporoparietal cortices are important areas for
modulating and triggering P300. Direct evidence for a
relationship between cortical abnormalities and reduced
P300 comes from McCarley et al. [73]. This research
group found that temporal lobe tissue loss in schizophren-
ics correlated significantly with changes in P300.
Moreover, animal studies reporting local microinjec-
tions of noradrenaline agonists and antagonists [46] in the
temporoparietal cortices of monkeys and observations of
single-unit activity in these cortices during discrimination
tasks in monkeys have indicated that these cortices are
generators of late positive P300 activity [74, 75].
In summary, P300 seems to be generated directly in
widespread cortical areas of the temporoparietal junction
and in the parietal cortices. Nevertheless, some indirect
influences of subcortical structures, like the limbic sys-
tem, have to be considered in explanations of P300 gener-
ation. These conclusions are in line with the reduced P300
amplitudes in patients with dementia of the Alzheimer
type, who show volume loss in the temporoparietal corti-
cal areas.
P300 Subcomponents
Findings from intracranial recordings, scalp data anal-
ysis and dipole source analysis suggest that various P300
subcomponents overlap at the surface scalp electrodes
and produce P300 with a maximum at the parietocentral
electrodes. The consequence is that functionally different
physiological processes overlap and are difficult to inves-
tigate. A methodological advance is the dipole source
model of P300, which is able to separate two P300 sub-
components directly from the surface scalp data [76].
These are a temporoparietal subcomponent, which seems
to correspond to the parietally recorded P300, and a tem-
porofrontal P300 subcomponent, which might corre-
spond to the frontally recorded P300.
Moreover, with intracranial recordings, multiple gen-
erators were suggested for the various P300 subcompo-
nents. Nevertheless, it remains unclear which of these
structures are far-field generators and are volume con-
ducted to the surface, and which are so-called closed-field
generators whose effects are locally restricted.
With intracranial recordings, three different wave-
forms can be observed in several brain sites [65, 66].
These waveforms are modality-specific auditory P300,
N2/P3a/SW components and P3b components, reflecting
different physiological processes [77, 78]. P3b, which is
generally regarded as the main component of P300, has a
maximum at parietocentral electrode sites, whereas P3a is
located over the frontal cortex and appears especially after
nontarget or novel stimuli. The slow wave has been
described as ‘negative-going’ over frontal areas and ‘posi-
tive-going’ over parietal areas [77, 79, 80].
P3b is the most prominent P300 subcomponent. Addi-
tionally, a modality-specific auditory P300 generator has
recently been found with intracranial recordings in the
dorsal superior temporal plane, especially when the non-
targets were subtracted from the targets [65, 66]. With
magnetoencephalographic recordings, the temporal plane
has been shown to play an important role in P300 genera-
tion [81]. Moreover, N2/P3a/SW components have been
observed in several diffusely distributed brain structures.
These triphasic waveforms have been found in the orbito-
frontal cortex, the anterior and posterior cingulate cor-
tices, the supramarginal gyrus and in some sites of the
temporal cortices [65, 66, 68, 82–84]. The prefrontal cor-
tex, which is thought to carry out some major integrative
functions, involving sensory as well as motoric and auto-
nomic processes [85], might play a role in the generation
of this P3a because P3a was significantly diminished in
both hemispheres after unilateral damage to the prefron-
tal cortex [86].
Summary of the Findings on P300 Generators
The P300 generators are localized in multiple cortical
areas. P300, also named P3b, seems to be generated in the
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parietal cortical areas and the temporoparietal cortices.
This component is most prominent in scalp data analysis
with a maximum over the parietocentral electrodes.
Moreover, to what extent other distinct waveforms can be
measured by the surface electrodes is unclear. N2/P3a/
SW waveforms seem to be elicited in multiple sites of the
frontal, temporal and parietal cortices. In auditory para-
digms, a modality-specific P3aud. seems to originate from
the superior temporal plane.
Conclusion
With respect to the neurochemical substrates and neu-
roanatomical generators of P300, there appears to be a
direct triggering by glutamatergic neurotransmission in
the temporoparietal junction, the parietal cortical areas
and, less evident, in the medial temporal lobe structures.
However, the activity of the medial temporal lobe struc-
tures does not seem to be volume conducted to the surface
and to have only little influence on the generation of the
scalp-recorded P300. This P300 activity is modulated
indirectly by cholinergic influences, enhancing P300 am-
plitudes and decreasing P300 latencies, and by GABAer-
gic influences, reducing P300 amplitudes and prolonging
P300 latencies. The adrenergic, dopaminergic and sero-
tonergic systems seem to be less important and to have
more indirect influence on other neurochemical systems
affecting P300, such as those of GABA and acetylcho-
line.
Recently, intracranial recordings and subcomponent
analysis have shown that P300 is composed of subcompo-
nents (P3b, P3a, SW, modality-specific auditory P300)
which have different scalp distributions, different un-
derlying neural generators and are modulated by different
neurochemical processes. In addition to this P3b compo-
nent, a modality-dependent auditory P300 generator has
been observed on the temporal plane of the gyrus tempo-
ralis superior and diffuse P3a/SW generators have been
found in multiple areas of the frontal, temporal and pari-
etal cortices. However, it remains unclear which of these
generators contribute to the surface P3a. Further studies
are necessary to identify these underlying generators and,
in particular, their neurochemical substrates.
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